Roche Pharma (Schweiz) AG
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 1662d91464
Drug names35First applicant · distinct drug namesAcceptance records273First applicant · distinct acceptance numbersUnder-review numbers34First applicant · current under-review listCo-applicant records31Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
273 acceptance records as first applicant, grouped into 35 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 6 records · Latest accepted 2026/10/23
Import · 2Supplement · 3Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600098 | Import | 2026/10/23 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2600270 | Supplement | 2026/09/23 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JXSS2600042 | Import | 2026/05/13 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2600112 | Supplement | 2026/05/08 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSZ2500033 | Import re-registration | 2025/10/09 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2500030 | Supplement | 2025/02/08 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2026/10/12
Import · 4Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600091 | Import | 2026/10/12 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JXSS2600090 | Import | 2026/10/12 | Roche Pharma (Schweiz) AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JYSB2500058 | Supplement | 2025/03/11 | Roche Pharma (Schweiz) AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JYSB2400268 | Supplement | 2024/12/24 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYSB2400267 | Supplement | 2024/12/21 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JXSS2300058 | Import | 2023/07/14 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JXSS2300030 | Import | 2023/04/11 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
No verified English name 14 records · Latest accepted 2026/09/21
Supplement · 12Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600260 | Supplement | 2026/09/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2600259 | Supplement | 2026/09/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2500247 | Supplement | 2025/10/18 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2500246 | Supplement | 2025/10/18 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2400207 | Supplement | 2024/09/12 | Roche Pharma（Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2400206 | Supplement | 2024/09/12 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2400191 | Supplement | 2024/08/26 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
| JYSB2400190 | Supplement | 2024/08/26 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
| JYSZ2400034 | Import re-registration | 2024/06/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; Roche（China）Holding Ltd | CDE ↗ |
| JYSZ2400033 | Import re-registration | 2024/06/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; Roche（China）Holding Ltd | CDE ↗ |
| JYSB2300156 | Supplement | 2023/09/12 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
| JYSB2300155 | Supplement | 2023/09/12 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
| JYSB2200018 | Supplement | 2022/02/11 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
| JYSB2200017 | Supplement | 2022/02/11 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd. | CDE ↗ |
Oseltamivir Phosphate Capsules 6 records · Latest accepted 2026/09/07
Supplement · 4Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600511 | Supplement | 2026/09/07 | Roche Pharma（Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHB2600510 | Supplement | 2026/09/07 | Roche Pharma（Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHZ2300224 | Import re-registration | 2023/05/13 | Roche Pharma （Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHZ2300223 | Import re-registration | 2023/05/13 | Roche Pharma （Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHB2200013 | Supplement | 2022/01/13 | Roche Pharma （Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHB2200012 | Supplement | 2022/01/13 | Roche Pharma （Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/09/03
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600089 | Import | 2026/09/03 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 12 records · Latest accepted 2026/09/02
Supplement · 9Import re-registration · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600243 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2600242 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2600241 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2300052 | Supplement | 2023/03/14 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2300051 | Supplement | 2023/03/14 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2300050 | Supplement | 2023/03/14 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2200158 | Supplement | 2022/08/23 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2200157 | Supplement | 2022/08/22 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSB2200156 | Supplement | 2022/08/22 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| JYSZ2200007 | Import re-registration | 2022/02/09 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200006 | Import re-registration | 2022/02/09 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200005 | Import re-registration | 2022/02/09 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 8 records · Latest accepted 2026/08/13
Supplement · 6Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600226 | Supplement | 2026/08/13 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2600225 | Supplement | 2026/08/13 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500225 | Supplement | 2025/09/19 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500224 | Supplement | 2025/09/19 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500037 | Supplement | 2025/02/14 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500036 | Supplement | 2025/02/14 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JXSS2300087 | Import | 2023/12/07 | Roche Pharma (Schweiz) AG; Genentech Inc.; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2300086 | Import | 2023/12/07 | Roche Pharma (Schweiz) AG; Genentech Inc.; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 11 records · Latest accepted 2026/08/10
Import re-registration · 2Supplement · 6Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSZ2600037 | Import re-registration | 2026/08/10 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2600161 | Supplement | 2026/06/17 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2400153 | Supplement | 2024/07/16 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2400036 | Supplement | 2024/02/28 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2200191 | Supplement | 2022/10/10 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2200155 | Supplement | 2022/08/16 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2200104 | Supplement | 2022/06/23 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2100533 | Import re-registration | 2021/12/16 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2100023 | Import | 2021/04/07 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2100021 | Import | 2021/04/01 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2000068 | Import | 2021/01/05 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/06/24
Supplement · 3Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600179 | Supplement | 2026/06/24 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2600046 | Supplement | 2026/02/14 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2300111 | Supplement | 2023/06/20 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JXSS2101004 | Import | 2021/04/21 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 16 records · Latest accepted 2026/06/17
Supplement · 10Import · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600332 | Supplement | 2026/06/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2600331 | Supplement | 2026/06/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2600180 | Supplement | 2026/03/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2600179 | Supplement | 2026/03/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2500437 | Supplement | 2025/08/21 | Roche Pharma (Schweiz) AG; 1）Catalent Greenville Inc.; 2）Recipharm Leganés S.L.U. | CDE ↗ |
| JYHB2500436 | Supplement | 2025/08/21 | Roche Pharma (Schweiz) AG; 1）Catalent Greenville Inc.; 2）Recipharm Leganés S.L.U. | CDE ↗ |
| JYHB2400517 | Supplement | 2024/10/01 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2400516 | Supplement | 2024/10/01 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2400452 | Supplement | 2024/08/15 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JYHB2400451 | Supplement | 2024/08/15 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| JXHS2300046 | Import | 2023/05/22 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc.; Roche（China）Holding Ltd. | CDE ↗ |
| JXHS2300045 | Import | 2023/05/22 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc.; Roche（China）Holding Ltd. | CDE ↗ |
| JXHS2101073 | Import | 2021/11/12 | Roche Pharma (Schweiz) AG; Mayne Pharma Inc.; Roche（China）Holding Ltd. | CDE ↗ |
| JXHS2101072 | Import | 2021/11/12 | Roche Pharma (Schweiz) AG; Mayne Pharma Inc.; Roche（China）Holding Ltd. | CDE ↗ |
| JXHS2101064 | Import | 2021/10/29 | Roche Pharma (Schweiz) AG; Mayne Pharma Inc.; Roche（China）Holding Ltd. | CDE ↗ |
| JXHS2101063 | Import | 2021/10/29 | Roche Pharma (Schweiz) AG; Mayne Pharma Inc.; Roche（China）Holding Ltd. | CDE ↗ |
No verified English name 11 records · Latest accepted 2026/06/04
Import · 4Supplement · 6Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600048 | Import | 2026/06/04 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2600040 | Import | 2026/04/23 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2600034 | Import | 2026/04/10 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2600025 | Import | 2026/04/02 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2600066 | Supplement | 2026/03/14 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600028 | Supplement | 2026/02/06 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2500035 | Import re-registration | 2025/10/28 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China）Holding Ltd. | CDE ↗ |
| JYSB2400034 | Supplement | 2024/02/19 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2400022 | Supplement | 2024/02/01 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2200008 | Supplement | 2022/01/18 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101079 | Supplement | 2021/07/08 | Roche Pharma(Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 12 records · Latest accepted 2026/05/18
Supplement · 11Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600127 | Supplement | 2026/05/18 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600126 | Supplement | 2026/05/18 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600034 | Supplement | 2026/02/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600033 | Supplement | 2026/02/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600009 | Supplement | 2026/01/09 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2500144 | Supplement | 2025/06/24 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500041 | Supplement | 2025/02/19 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2400215 | Supplement | 2024/09/25 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2400214 | Supplement | 2024/09/25 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2400211 | Supplement | 2024/09/25 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JXSS2400072 | Import | 2024/09/05 | Roche Pharma (Schweiz) AG; Genentech Inc.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2400193 | Supplement | 2024/08/28 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
No verified English name 18 records · Latest accepted 2026/05/09
Supplement · 13Import re-registration · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600116 | Supplement | 2026/05/09 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2600115 | Supplement | 2026/05/09 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2600099 | Supplement | 2026/04/18 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2300075 | Supplement | 2023/04/26 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300074 | Supplement | 2023/04/26 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300073 | Supplement | 2023/04/26 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300072 | Supplement | 2023/04/26 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300071 | Supplement | 2023/04/26 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2200046 | Import re-registration | 2022/08/30 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200045 | Import re-registration | 2022/08/30 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200044 | Import re-registration | 2022/08/30 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200043 | Import re-registration | 2022/08/30 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSZ2200042 | Import re-registration | 2022/08/30 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2200154 | Supplement | 2022/08/12 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2200153 | Supplement | 2022/08/12 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2200152 | Supplement | 2022/08/12 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2200151 | Supplement | 2022/08/12 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| JYSB2200150 | Supplement | 2022/08/12 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
Baloxavir Marboxil Tablets 11 records · Latest accepted 2026/05/07
Import · 1Import re-registration · 2Supplement · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600140 | Import | 2026/05/07 | Roche Pharma (Schweiz) AG | CDE ↗ |
| JYHZ2500178 | Import re-registration | 2025/08/06 | Roche Pharma (Schweiz) AG; 1）Shionogi Pharma Co. Ltd.; 2）Avara Pharmaceutical Technologies Inc.; N/A | CDE ↗ |
| JYHZ2500177 | Import re-registration | 2025/08/06 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd.; N/A | CDE ↗ |
| JYHB2500316 | Supplement | 2025/06/12 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
| JYHB2500315 | Supplement | 2025/06/12 | Roche Pharma (Schweiz) AG; 1）Shionogi Pharma Co. Ltd.; 2）Avara Pharmaceutical Technologies Inc. | CDE ↗ |
| JYHB2300264 | Supplement | 2023/04/25 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd | CDE ↗ |
| JYHB2300112 | Supplement | 2023/02/11 | Roche Pharma (Schweiz) AG; 1）Shionogi Pharma Co. Ltd.; 2）Avara Pharmaceutical Technologies Inc. | CDE ↗ |
| JYHB2200523 | Supplement | 2022/09/23 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
| JYHB2200522 | Supplement | 2022/09/23 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
| JYHB2101293 | Supplement | 2021/07/30 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
| JYHB2101292 | Supplement | 2021/07/30 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/16
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2600039 | Import | 2026/04/16 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/04/15
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600094 | Supplement | 2026/04/15 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2500286 | Supplement | 2025/12/16 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSB2400169 | Supplement | 2024/12/14 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSB2400168 | Supplement | 2024/12/14 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/03/11
Supplement · 1Import · 1
No verified English name 4 records · Latest accepted 2026/03/06
Supplement · 2Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600060 | Supplement | 2026/03/06 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2600059 | Supplement | 2026/03/06 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2300065 | Import | 2023/07/28 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2300064 | Import | 2023/07/28 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 8 records · Latest accepted 2026/02/14
Supplement · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600045 | Supplement | 2026/02/14 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2600044 | Supplement | 2026/02/14 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2500205 | Supplement | 2025/09/06 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2500204 | Supplement | 2025/09/06 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2400171 | Supplement | 2024/08/03 | Roche Pharma（Schweiz）AG | CDE ↗ |
| JYSB2400170 | Supplement | 2024/08/03 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2400139 | Supplement | 2024/06/28 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| JYSB2400138 | Supplement | 2024/06/28 | Roche Pharma（Schweiz）AG | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/01/17
Supplement · 2Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600048 | Supplement | 2026/01/17 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYHB2500546 | Supplement | 2025/10/18 | Roche Pharma (Schweiz) AG; Robert Ferraro; Nicolas Gut | CDE ↗ |
| JXHS2400063 | Import | 2024/09/12 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/12/05
Import re-registration · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2500275 | Import re-registration | 2025/12/05 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG; F.Hoffmann-La Roche Ltd; Roche (China) Holding Ltd. | CDE ↗ |
| JYHB2500507 | Supplement | 2025/09/28 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| JYHB2400196 | Supplement | 2024/05/06 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
No verified English name 30 records · Latest accepted 2025/11/29
Import · 10Import re-registration · 4Supplement · 16
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2500147 | Import | 2025/11/29 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500146 | Import | 2025/11/29 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2500029 | Import re-registration | 2025/09/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2500028 | Import re-registration | 2025/09/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2500027 | Import re-registration | 2025/09/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2500026 | Import re-registration | 2025/09/12 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500036 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500035 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500034 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500033 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500032 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500031 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500030 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JXSS2500029 | Import | 2025/03/22 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300192 | Supplement | 2023/11/07 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300191 | Supplement | 2023/11/07 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300190 | Supplement | 2023/11/07 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300189 | Supplement | 2023/11/07 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300020 | Supplement | 2023/02/07 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300019 | Supplement | 2023/02/07 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300018 | Supplement | 2023/02/07 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300017 | Supplement | 2023/02/07 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101048 | Supplement | 2021/06/04 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101047 | Supplement | 2021/06/04 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101046 | Supplement | 2021/06/04 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101045 | Supplement | 2021/06/04 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2100035 | Supplement | 2021/01/27 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2100034 | Supplement | 2021/01/27 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2100033 | Supplement | 2021/01/27 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2100032 | Supplement | 2021/01/27 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 12 records · Latest accepted 2025/11/28
Supplement · 10Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500275 | Supplement | 2025/11/28 | Roche Pharma（Schweiz）AG; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2500274 | Supplement | 2025/11/28 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JXSS2500069 | Import | 2025/05/28 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
| JXSS2500068 | Import | 2025/05/28 | Roche Pharma (Schweiz) AG; BSP Pharmaceuticals S.p.A.; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2400121 | Supplement | 2024/06/07 | Roche Pharma（Schweiz）AG; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2400120 | Supplement | 2024/06/07 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYSB2400068 | Supplement | 2024/03/27 | Roche Pharma（Schweiz）AG; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2400067 | Supplement | 2024/03/27 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYSB2300173 | Supplement | 2023/10/09 | Roche Pharma（Schweiz）AG; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2300172 | Supplement | 2023/10/09 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYSB2300082 | Supplement | 2023/05/06 | Roche Pharma（Schweiz）AG; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2300081 | Supplement | 2023/05/06 | Roche Pharma（Schweiz）AG; F. Hoffmann-La Roche AG | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/08/23
Import · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500090 | Import | 2025/08/23 | Roche Pharma (Schweiz) AG; 1）Shionogi Pharma Co. Ltd.; 2）Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400144 | Supplement | 2024/04/02 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd.; Rottendorf Pharma GmbH | CDE ↗ |
| JXHS2200111 | Import | 2022/11/22 | Roche Pharma (Schweiz) AG; Shionogi Pharma Co. Ltd. | CDE ↗ |
No verified English name 11 records · Latest accepted 2025/08/19
Supplement · 10Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500191 | Supplement | 2025/08/19 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH; Genentech Inc. | CDE ↗ |
| JYSB2400254 | Supplement | 2024/12/09 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH; Genentech Inc. | CDE ↗ |
| JYSB2300197 | Supplement | 2023/11/14 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSZ2300019 | Import re-registration | 2023/04/21 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| JYSB2300063 | Supplement | 2023/04/11 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH; Genentech Inc. | CDE ↗ |
| JYSB2300016 | Supplement | 2023/02/07 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2300009 | Supplement | 2023/01/17 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2200111 | Supplement | 2022/06/30 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101061 | Supplement | 2021/06/25 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2101013 | Supplement | 2021/04/23 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| JYSB2000696 | Supplement | 2021/01/05 | Roche Pharma（Schweiz)AG; Roche Diagnostics GmbH | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/08/01
Supplement · 4Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500398 | Supplement | 2025/08/01 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYHB2500397 | Supplement | 2025/08/01 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYHB2500242 | Supplement | 2025/04/28 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JYHB2500241 | Supplement | 2025/04/28 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| JXHS2400038 | Import | 2024/06/03 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
| JXHS2400037 | Import | 2024/06/03 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 9 records · Latest accepted 2025/06/25
Supplement · 6Import re-registration · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500149 | Supplement | 2025/06/25 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500148 | Supplement | 2025/06/25 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2500147 | Supplement | 2025/06/25 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2300119 | Supplement | 2023/07/12 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2300118 | Supplement | 2023/07/12 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSB2300117 | Supplement | 2023/07/12 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| JYSZ2200058 | Import re-registration | 2022/11/01 | Roche Pharma (Schweiz) AG; Genentech Inc.; Shanghai Roche Pharmaceuticals Ltd. | CDE ↗ |
| JYSZ2200057 | Import re-registration | 2022/11/01 | Roche Pharma (Schweiz) AG; Genentech Inc.; Shanghai Roche Pharmaceuticals Ltd. | CDE ↗ |
| JYSZ2200056 | Import re-registration | 2022/11/01 | Roche Pharma (Schweiz) AG; Genentech Inc.; Shanghai Roche Pharmaceuticals Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/05/15
Supplement · 2
No verified English name 28 records · Latest accepted 2025/03/20
Supplement · 24Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500074 | Supplement | 2025/03/20 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2500073 | Supplement | 2025/03/20 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2500072 | Supplement | 2025/03/20 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2500071 | Supplement | 2025/03/20 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2500067 | Supplement | 2025/03/18 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Samsung Biologics Co. Ltd. | CDE ↗ |
| JYSB2500066 | Supplement | 2025/03/18 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Samsung Biologics Co. Ltd. | CDE ↗ |
| JYSB2500065 | Supplement | 2025/03/18 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Samsung Biologics Co. Ltd. | CDE ↗ |
| JYSB2500064 | Supplement | 2025/03/18 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd.; Samsung Biologics Co. Ltd. | CDE ↗ |
| JYSZ2300018 | Import re-registration | 2023/03/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd; Roche （China）Holding Ltd | CDE ↗ |
| JYSZ2300017 | Import re-registration | 2023/03/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd; Roche （China）Holding Ltd | CDE ↗ |
| JYSZ2300016 | Import re-registration | 2023/03/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd; Roche （China）Holding Ltd | CDE ↗ |
| JYSZ2300015 | Import re-registration | 2023/03/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd; Roche （China）Holding Ltd | CDE ↗ |
| JYSB2300048 | Supplement | 2023/03/08 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2300047 | Supplement | 2023/03/08 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2300046 | Supplement | 2023/03/08 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2300045 | Supplement | 2023/03/08 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2200170 | Supplement | 2022/08/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2200169 | Supplement | 2022/08/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2200168 | Supplement | 2022/08/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2200167 | Supplement | 2022/08/30 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101179 | Supplement | 2021/11/29 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101178 | Supplement | 2021/11/29 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101177 | Supplement | 2021/11/29 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101176 | Supplement | 2021/11/29 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101059 | Supplement | 2021/06/25 | Roche Pharma(Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101058 | Supplement | 2021/06/25 | Roche Pharma(Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101057 | Supplement | 2021/06/25 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
| JYSB2101056 | Supplement | 2021/06/25 | Roche Pharma(Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/02/01
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2300014 | Import | 2023/02/01 | Roche Pharma (Schweiz) AG; Genentech Inc.; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/08/12
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2200032 | Import | 2022/08/12 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd | CDE ↗ |
| JXSS2200030 | Import | 2022/08/04 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/08/10
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2200031 | Import | 2022/08/10 | Roche Pharma (Schweiz) AG; Genentech Inc.; Roche (China) Holding Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/07/27
Import · 2
No verified English name 2 records · Latest accepted 2021/12/30
Import · 2
No verified English name 2 records · Latest accepted 2021/12/02
Import · 2
Changes in the last 90 days
12 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 12 applications
- 2026/10/23Accepted
No verified English name
JXSS2600098
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/10/12Accepted
No verified English name
JXSS2600091
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
No verified English name
JXSS2600090
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JYSB2600270
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/21Accepted
No verified English name
JYSB2600260
Fact date: 2026/09/21 · Site observation date: 2026/10/22
View source ↗ - 2026/09/21Accepted
No verified English name
JYSB2600259
Fact date: 2026/09/21 · Site observation date: 2026/10/22
View source ↗ - 2026/09/07Accepted
Oseltamivir Phosphate Capsules
JYHB2600511
Fact date: 2026/09/07 · Site observation date: 2026/10/22
View source ↗ - 2026/09/07Accepted
Oseltamivir Phosphate Capsules
JYHB2600510
Fact date: 2026/09/07 · Site observation date: 2026/10/22
View source ↗ - 2026/09/03Accepted
No verified English name
JXSS2600089
Fact date: 2026/09/03 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JYSB2600243
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JYSB2600242
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JYSB2600241
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗
Under review
34 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JXSS2600098 | Import | 2026/10/23 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JXSS2600091 | Import | 2026/10/12 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG | CDE ↗ |
| No verified English name | JXSS2600090 | Import | 2026/10/12 | Roche Pharma (Schweiz) AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| No verified English name | JYSB2600270 | Supplement | 2026/09/23 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600260 | Supplement | 2026/09/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| No verified English name | JYSB2600259 | Supplement | 2026/09/21 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd | CDE ↗ |
| Oseltamivir Phosphate Capsules | JYHB2600511 | Supplement | 2026/09/07 | Roche Pharma（Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| Oseltamivir Phosphate Capsules | JYHB2600510 | Supplement | 2026/09/07 | Roche Pharma（Schweiz）AG; Delpharm Milano S.r.l. | CDE ↗ |
| No verified English name | JXSS2600089 | Import | 2026/09/03 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYSB2600243 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600242 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600241 | Supplement | 2026/09/02 | Roche Pharma (Schweiz) AG; Chugai Pharma Manufacturing Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600226 | Supplement | 2026/08/13 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| No verified English name | JYSB2600225 | Supplement | 2026/08/13 | Roche Pharma (Schweiz) AG; Genentech Inc. | CDE ↗ |
| No verified English name | JYSZ2600037 | Import re-registration | 2026/08/10 | Roche Pharma（Schweiz）AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYHB2600332 | Supplement | 2026/06/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| No verified English name | JYHB2600331 | Supplement | 2026/06/17 | Roche Pharma (Schweiz) AG; Catalent Greenville Inc. | CDE ↗ |
| No verified English name | JXSS2600048 | Import | 2026/06/04 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JXSS2600042 | Import | 2026/05/13 | Roche Pharma (Schweiz) AG; Utsunomiya Plant of Chugai Pharma Manufacturing Co. Ltd.; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYSB2600116 | Supplement | 2026/05/09 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| No verified English name | JYSB2600115 | Supplement | 2026/05/09 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| No verified English name | JXSS2600040 | Import | 2026/04/23 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYSB2600099 | Supplement | 2026/04/18 | Roche Pharma (Schweiz) AG; F.Hoffmann-La Roche AG | CDE ↗ |
| No verified English name | JXHS2600039 | Import | 2026/04/16 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche AG; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYSB2600094 | Supplement | 2026/04/15 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| No verified English name | JXSS2600034 | Import | 2026/04/10 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JXSS2600025 | Import | 2026/04/02 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH; Roche (China) Holding Ltd. | CDE ↗ |
| No verified English name | JYSB2600066 | Supplement | 2026/03/14 | Roche Pharma (Schweiz) AG; Roche Diagnostics GmbH | CDE ↗ |
| No verified English name | JYSB2500247 | Supplement | 2025/10/18 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| No verified English name | JYSB2500246 | Supplement | 2025/10/18 | Roche Pharma（Schweiz) AG; F.Hoffmann-La Roche Ltd.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| No verified English name | JYSB2500205 | Supplement | 2025/09/06 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| No verified English name | JYSB2500204 | Supplement | 2025/09/06 | Roche Pharma (Schweiz) AG; F. Hoffmann-La Roche Ltd | CDE ↗ |
| No verified English name | JYHB2500437 | Supplement | 2025/08/21 | Roche Pharma (Schweiz) AG; 1）Catalent Greenville Inc.; 2）Recipharm Leganés S.L.U. | CDE ↗ |
| No verified English name | JYSB2400254 | Supplement | 2024/12/09 | Roche Pharma（Schweiz) AG; Roche Diagnostics GmbH; Genentech Inc. | CDE ↗ |
Catalogue holder records
0 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
2 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Roche Pharma (Schweiz) AG | Y20190000656 | A | 2026/06/16 | CDE ↗ |
| No verified English name | Roche Pharma (Schweiz) AG | Y20209990030 | A | 2026/06/24 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
31 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTH2600087 | Not stated by source | 2026/04/30 | Recipharm Leganés S.L.U; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600052 | Not stated by source | 2026/04/09 | F. Hoffmann？La Roche Ltd; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600051 | Not stated by source | 2026/04/09 | Roche Diagnostics GmbH; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600045 | Not stated by source | 2026/03/19 | F. Hoffmann-La Roche AG; Roche Pharma（Schweiz）AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600044 | Not stated by source | 2026/03/19 | BSP Pharmaceuticals S.p.A.; Roche Pharma（Schweiz）AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600043 | Not stated by source | 2026/03/19 | F. Hoffmann-La Roche AG; Roche Pharma（Schweiz）AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600034 | Not stated by source | 2026/03/10 | BSP Pharmaceuticals S.p.A.; Roche Pharma（Schweiz）AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2600037 | Not stated by source | 2026/02/15 | Rottendorf Pharma GmbH; Roche Pharma (Schweiz) AG; Shanghai Luo Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500195 | Not stated by source | 2025/12/19 | F. Hoffmann-La Roche AG; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Baloxavir Marboxil Tablets | JTH2500191 | Not stated by source | 2025/12/11 | Shionogi Pharma Co. Ltd; Roche Pharma (Schweiz) AG; Shanghai Luo Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500149 | Not stated by source | 2025/10/15 | Recipharm Leganés S.L.U; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Baloxavir Marboxil Tablets | JTH2500116 | Not stated by source | 2025/07/23 | Shionogi Pharma Co. Ltd; Roche Pharma (Schweiz) AG; Shanghai Luo Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500012 | Not stated by source | 2025/02/08 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500011 | Not stated by source | 2025/02/08 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400004 | Not stated by source | 2024/01/05 | F.Hoffmann-La Roche AG; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Baloxavir Marboxil Tablets | JTH2300222 | Not stated by source | 2023/09/14 | Shionogi Pharma Co. Ltd.; Roche Pharma (Schweiz) AG; Shanghai Luo Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Baloxavir Marboxil Tablets | JTH2300202 | Not stated by source | 2023/08/23 | Shionogi Pharma Co. Ltd.; Roche Pharma (Schweiz) AG; Shanghai Luo Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200041 | Not stated by source | 2022/06/09 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200040 | Not stated by source | 2022/06/09 | F. Hoffmann-La Roche Ltd; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200039 | Not stated by source | 2022/06/09 | F. Hoffmann-La Roche Ltd; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200035 | Not stated by source | 2022/06/02 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200034 | Not stated by source | 2022/06/02 | Roche Diagnostics GmbH; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100539 | Not stated by source | 2021/10/22 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100538 | Not stated by source | 2021/10/22 | Genentech Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100535 | Not stated by source | 2021/10/19 | Roche Diagnostics GmbH; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100507 | Not stated by source | 2021/07/19 | Lonza AG; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100506 | Not stated by source | 2021/07/19 | BSP Pharmaceuticals S.p.A.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100079 | Not stated by source | 2021/03/24 | Mayne Pharma Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100078 | Not stated by source | 2021/03/24 | Mayne Pharma Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100074 | Not stated by source | 2021/03/17 | Mayne Pharma Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100073 | Not stated by source | 2021/03/17 | Mayne Pharma Inc.; Roche Pharma (Schweiz) AG; Luo Shi (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.